Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Total Non-Current Liabilities (2020 - 2025)

IceCure Medical (ICCM) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $161000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Total Non-Current Liabilities fell 57.18% to $161000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $161000.0, a 57.18% decrease, with the full-year FY2024 number at $161000.0, down 57.18% from a year prior.
  • Total Non-Current Liabilities was $161000.0 for Q4 2024 at IceCure Medical, down from $376000.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.3 million in Q4 2021 to a low of $161000.0 in Q4 2024.
  • A 5-year average of $629400.0 and a median of $430000.0 in 2022 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: soared 48.57% in 2021, then tumbled 67.0% in 2022.
  • IceCure Medical's Total Non-Current Liabilities stood at $877000.0 in 2020, then skyrocketed by 48.57% to $1.3 million in 2021, then crashed by 67.0% to $430000.0 in 2022, then decreased by 12.56% to $376000.0 in 2023, then plummeted by 57.18% to $161000.0 in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Total Non-Current Liabilities are $161000.0 (Q4 2024), $376000.0 (Q4 2023), and $430000.0 (Q4 2022).